N
NRx Pharmaceuticals, Inc. (NRXP)
NCM – Real Time Price. Currency in USD
3.73
+0.17 (4.78%)
At close: Jun 26, 2026, 4:00 PM EDT
3.81
+0.08 (2.14%)
After-hours: Jun 26, 2026, 7:38 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
3.73
+0.17 (4.78%)
At close: Jun 26, 2026, 4:00 PM EDT
3.81
+0.08 (2.14%)
After-hours: Jun 26, 2026, 7:38 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $6.7M significantly exceed its total debt $934.0K, ensuring strong financial flexibility
Total current liabilities $25.2M surpass Total current assets $7.4M, signaling liquidity issues
Debt-to-equity ratio (-0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-20.4x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$4.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.29 | 6.05 | 3.0 | |
| Quick ratio | 0.29 | 5.63 | 3.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.08 | 1.04 | 9.0 | |
| Interest coverage | -20.38 | -16.91 | 1.0 | |
| Weighted average score | 3.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | 1M | 2M |
| Gross Profit | -4K | -5K | -5K | 577K | 851K |
| Operating Income | -44M | -28M | -20M | -16M | -17M |
| Net Income | -40M | -30M | -25M | -29M | -25M |
| EBITDA | -44M | -28M | -20M | -16M | -17M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 88.48 | 5.5 |
| Next quarter | 999.69 | 60.72 | 10 |
| Current year | 1034.18 | 72.07 | 10 |
| Next year | 1091.94 | 194.21 | 10 |
| Weighted average score | 8.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 8.65 | -497.21 | -499.99 | -15.66 | 2.3 |
| Y/Y | 999 | 74.06 | 88.24 | -23.41 | 7.8 |
| 3y average | 999 | 8.97 | 39.55 | 21.25 | 9.0 |
| 5y average | 999 | 0.89 | 39.55 | -300.95 | 5.8 |
| Weighted average score | 6.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |